Talecris Biotherapeutics Holdings Corp. (TLCR) has 4 open-market insider trades by 4 insiders since 2009. The most active filer is Stephen Feinberg, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Stephen Feinberg | 10% | — | 1 | $485.9M | 2009-10-06 |
| 2001 Lp Ampersand | 10% | — | 1 | $132.0M | 2011-06-01 |
| Mary J. Kuhn | Executive VPOperations | — | 1 | $759K | 2011-06-01 |
| Kari D. Heerdt | Sr. VPHuman Resources | — | 1 | $410K | 2011-06-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Joel E. Abelson | Sr VP & GM & Int'l Bus. | Sell | $366K | 2011-02-01 |
| Stephen R. Petteway Jr. | Executive VP & R&D | Sell | $609K | 2011-02-01 |
| Mary J. Kuhn | Executive VP & Operations | Sell | $1.3M | 2011-02-01 |
| Mary J. Kuhn | Executive VP & Operations | Sell | $1.3M | 2011-01-03 |
| Joel E. Abelson | Sr VP & GM & Int'l Bus. | Sell | $1.0M | 2011-01-03 |
| Stephen R. Petteway Jr. | Executive VP & R&D | Sell |
Companies that share insiders with TLCR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $577K |
| 2011-01-03 |
| James R. Engle | Sr. VP & Information Technology | Sell | $589K | 2010-12-01 |
| Stephen R. Petteway Jr. | Executive VP & R&D | Sell | $538K | 2010-12-01 |
| Stephen R. Petteway Jr. | Executive VP & R&D | Sell | $609K | 2010-11-01 |
| Mary J. Kuhn | Executive VP & Operations | Sell | $1.1M | 2010-11-01 |
| James R. Engle | Sr. VP & Information Technology | Sell | $308K | 2010-11-01 |
| Mary J. Kuhn | Executive VP & Operations | Sell | $1.1M | 2010-10-01 |
| Stephen R. Petteway Jr. | Executive VP & R&D | Sell | $570K | 2010-10-01 |
| Joel E. Abelson | Sr VP & GM & Int'l Bus. | Sell | $685K | 2010-10-01 |
| James R. Engle | Sr. VP & Information Technology | Sell | $842K | 2010-10-01 |